SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000940397-21-000002
Filing Date
2021-06-28
Accepted
2021-06-28 11:17:56
Documents
2

Document Format Files

Seq Description Document Type Size
1 13D/A2 acurapharm13dajune2021.htm SC 13D/A 60288
2 image0.jpg GRAPHIC 71472
  Complete submission text file 0000940397-21-000002.txt   159966
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Subject) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-78982 | Film No.: 211051066
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9707 SHELBYVILLE ROAD LOUISVILLE KY 40233
Business Address
Schutte John (Filed by) CIK: 0001713580 (see all company filings)

Type: SC 13D/A